Suppr超能文献

比较 1 至 3 个腋窝淋巴结阳性患者中保乳手术联合放疗与全乳切除术不联合放疗的治疗效果。

Comparison of treatment outcome between breast-conservation surgery with radiation and total mastectomy without radiation in patients with one to three positive axillary lymph nodes.

机构信息

Department of Surgery, Yonsei University College of Medicine, Seoul, Korea.

出版信息

Int J Radiat Oncol Biol Phys. 2011 Aug 1;80(5):1446-52. doi: 10.1016/j.ijrobp.2010.04.051. Epub 2010 Aug 24.

Abstract

PURPOSE

To test the difference in treatment outcome between breast-conservation surgery with radiation and total mastectomy without radiation, to evaluate the benefits of adjuvant radiotherapy in patients with one to three positive axillary lymph nodes.

METHODS AND MATERIALS

Using the Severance Hospital Breast Cancer Registry, we divided the study population of T1, T2 and one to three axillary node-positive patients into two groups: breast-conservation surgery with radiation (BCS/RT) and total mastectomy without radiation (TM/no-RT). Data related to locoregional recurrence, distant recurrence, and death were collected, and survival rates were calculated.

RESULTS

The study population consisted of 125 patients treated with BCS/RT and 365 patients treated with TM/no-RT. With a median follow-up of 68.4 months, the 10-year locoregional recurrence-free survival rate with BCS/RT and TM/no-RT was 90.5% and 79.2%, respectively (p = 0.056). The 10-year distant recurrence-free survival rate was 78.8% for patients treated with BCS/RT vs. 68.0% for those treated with TM/no-RT (p = 0.012). The 10-years overall survival rate for patients treated with BCT/RT and TM/no-RT was 87.5% and 73.9%, respectively (p = 0.035). After multivariate analysis, patients treated with BCT/RT had better distant recurrence-free survival (hazard ratio [HR], 0.527; 95% confidence interval [CI], 0.297-0.934; p = 0.028), with improving locoregional recurrence-free survival (HR, 0.491; 95% CI, 0.231-1.041; p = 0.064) and overall survival trend (HR, 0.544; 95% CI, 0.277-1.067; p = 0.076).

CONCLUSIONS

This study provides additional evidence that adjuvant radiation substantially reduces local recurrence, distant recurrence, and mortality for patients with one to three involved nodes.

摘要

目的

检验保乳手术联合放疗与单纯乳房切除术不联合放疗在治疗结果上的差异,评估辅助放疗在 1-3 个腋窝淋巴结阳性患者中的获益。

方法和材料

利用首尔峨山医院乳腺癌注册数据库,我们将 T1、T2 期和 1-3 个腋窝淋巴结阳性患者的研究人群分为两组:保乳手术联合放疗(BCS/RT)和单纯乳房切除术不联合放疗(TM/no-RT)。收集局部区域复发、远处复发和死亡相关的数据,并计算生存率。

结果

本研究共纳入 125 例接受 BCS/RT 治疗的患者和 365 例接受 TM/no-RT 治疗的患者。中位随访时间为 68.4 个月,BCS/RT 和 TM/no-RT 的 10 年局部区域无复发生存率分别为 90.5%和 79.2%(p = 0.056)。接受 BCS/RT 治疗的患者的 10 年远处无复发生存率为 78.8%,而接受 TM/no-RT 治疗的患者为 68.0%(p = 0.012)。接受 BCT/RT 和 TM/no-RT 治疗的患者的 10 年总生存率分别为 87.5%和 73.9%(p = 0.035)。多因素分析后,接受 BCT/RT 治疗的患者远处无复发生存率更好(风险比 [HR],0.527;95%置信区间 [CI],0.297-0.934;p = 0.028),局部区域无复发生存率有改善趋势(HR,0.491;95% CI,0.231-1.041;p = 0.064),总生存趋势也有改善(HR,0.544;95% CI,0.277-1.067;p = 0.076)。

结论

本研究提供了额外的证据,表明辅助放疗可显著降低 1-3 个淋巴结受累患者的局部复发、远处复发和死亡率。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验